Using ultrasound to create temporary visual disruptions for personalized brain stimulation
Official title: Developing a Method of Adjusting the Strength of Transcranial Focused Ultrasound (tFUS) to Personalize Treatment.
Run by Medical University of South Carolina · NCT06426498 · Data updated 2026-11-12
This study is testing a new ultrasound technique to see how different levels of brain stimulation affect people's vision in healthy individuals.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Status | Recruiting |
| Started | June 20, 2024 |
| Main results expected | May 20, 2027 |
| Study ends | August 20, 2027 |
| Registry record updated | May 29, 2026 |
| Trial ID | NCT06426498 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 18-70 with normal or corrected-to-normal vision and hearing.
✕Probably not a fit
Patients with neurological or psychological illnesses, or those currently using psychoactive medications, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research focuses on developing a technique using transcranial Focused Ultrasound Stimulation (tFUS) to measure brain stimulation effects in individuals. The study aims to identify the minimum effective dose of tFUS by inducing a temporary visual field change, known as a scotoma. Researchers will assess whether different types of visual detection are affected by varying tFUS doses. The approach is noninvasive and targets healthy individuals to establish baseline measurements.
Why it matters
Potential benefit: If successful, this technique could lead to more personalized and effective brain stimulation therapies.
How similar studies have gone: While the use of tFUS is a novel approach, similar studies in brain stimulation have shown promising results, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female * Age 18-70 * Normal or corrected-to normal vision and hearing * No neurological or psychological illness Exclusion Criteria: * Diagnosis of any depressive or anxiety disorder * Diagnosis of schizophrenia or bipolar disorder * Current use of any non-prescribed psychoactive medications or drugs * Contraindication to enter the MRI environment. * Pregnancy (or suspected/possible pregnancy or plan to become pregnant in the short term). * Urine Pregnancy Test: If the subject is a woman of childbearing potential and /or a man capable of fathering a child before, during, and/or after participation precaution should be taken. Examples of acceptable methods of birth control for participants involved in the study include: birth control pills, patch, IUD, condom, sponge, diaphragm with spermicide, or avoiding sexual activity that could cause the subject to become pregnant. * Inability to adhere to treatment schedule. * Initiation of new antidepressant treatment at the time of study randomization. NOTE: There will be no exclusion based upon gender or minority status. We anticipate that at least 50% of the participants will be women. The percentage of minority participants is expected to be at least 5%. We will make vigorous attempts to increase this number by posting advertisement flyers in minority communities. Children, prisoners, and institutionalized individuals will not be recruited, because they are beyond the scope of the objectives. Moreover, we will emphasize that participation in this study is completely voluntary. Recruitment of women and minorities has been addressed above. Non-English speaking subjects will not be recruited because they may not be able to understand instructions, which could undermine the validity of the results.
Where it's running
-
Medical University of South Carolina Brain Stimulation Division
Charleston, South Carolina, United States Recruiting
Study contacts
- Study coordinator: Bridgette Holland
- Email: hollanbr@musc.edu
- Phone: 843 638 7517
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sex differences in how cannabis affects people who regularly use it
This Phase 2 trial tests whether men and women who use cannabis several days a week respond differently to THC versus placebo.
-
taVNS added to oral motor training for babies with severe swallowing trouble
This trial tests whether pairing a noninvasive taVNS treatment with oral sensorimotor training helps infants in NICUs swallow better and feed more safely.
-
Personalized chemoimmunotherapy for early TNBC with high TILs (no anthracyclines upfront)
This trial tests a 12-week, anthracycline-free neoadjuvant regimen of carboplatin, paclitaxel, and pembrolizumab in early-stage TNBC with high TILs to see if surgery outcomes are as good as historical regimens.
-
Parietal brain stimulation for memory in Parkinson’s with mild cognitive impairment
This study tests whether a short, high-dose burst of brain stimulation to the right superior parietal area can safely and feasibly help people with Parkinson’s-related cognitive impairment.
-
Smell training plus non-invasive nerve stimulation to boost sense of smell
This test will try adding non-invasive trigeminal nerve stimulation to standard smell training for adults with smell loss to see if it improves olfactory function.
-
Olfactory-focused low-intensity ultrasound on smell perception in healthy adults
This study tests whether gentle, targeted ultrasound can change how healthy adults perceive odors and respond to them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.